Infliximab paradoxical psoriasis in a cohort of children with inflammatory bowel disease

Olivier Courbette,Camille Aupiais,Jérôme Viala,Jean-Pierre Hugot,Baptiste Louveau,Lucienne Chatenoud,Emmanuelle Bourrat,Christine Martinez-Vinson

Infliximab paradoxical psoriasis in a cohort of children with inflammatory bowel disease

2019

Olivier Courbette
Camille Aupiais
Jérôme Viala
Jean-Pierre Hugot
Baptiste Louveau
Lucienne Chatenoud
Emmanuelle Bourrat
Christine Martinez-Vinson

ABSTRACTObjectives:In adult inflammatory bowel disease (IBD) treated by anti-TNF antibodies, paradoxical psoriasis has an estimated prevalence of 1.6 to 22%, especially in infliximab (IFX)-treated patients. Little is known in the pediatric IBD (PIBD) populations.Methods:All patients aged from 2 to 1

Keywords:

Internal medicine
Endocrinology
Medicine
Psoriasis
Cohort
Infliximab
Diabetes mellitus
Inflammatory bowel disease
Retrospective cohort study
Interquartile range
Ulcerative colitis
Gastroenterology
Side effect

Correction
Source
Cite
Save
Machine Reading By IdeaReader

References

Citations